𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Unmasking of Chronic Myelomonocytic Leukemia after Treatment of Chronic Lymphocytic Leukemia with Rituximab

✍ Scribed by Bobek, Lesley N.; Hyde, Jason K.; Hansen, Keith S.

Book ID
122611679
Publisher
CIG Media Group, LP.
Year
2007
Tongue
English
Weight
346 KB
Volume
1
Category
Article
ISSN
1931-6925

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Treatment of chronic lymphocytic leukemi
Treatment of chronic lymphocytic leukemia
✍ Alessandra Ferrajoli; Susan M O’Brien πŸ“‚ Article πŸ“… 2004 πŸ› Elsevier Science 🌐 English βš– 87 KB
Early treatment of high-risk chronic lym
Early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab
✍ Clive S. Zent; Timothy G. Call; Tait D. Shanafelt; Renee C. Tschumper; Diane F. πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 162 KB

## Abstract ## BACKGROUND. Patients with chronic lymphocytic leukemia (CLL) usually are treated only for progressive disease. However, the discovery of biologic predictors of a high risk of disease progression, together with the development of newer, more targeted therapies, could change this para